相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Coexpression profile of leukemic stem cell markers for combinatorial targeted therapy in AML
S. Haubner et al.
LEUKEMIA (2019)
CD9 expression indicates a poor outcome in acute lymphoblastic leukemia
Peiqi Liang et al.
CANCER BIOMARKERS (2018)
Universal monitoring of minimal residual disease in acute myeloid leukemia
Elaine Coustan-Smith et al.
JCI INSIGHT (2018)
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
Hartmut Doehner et al.
BLOOD (2017)
Prognostic significance of CD9 expression differs between tumour cells and stromal immune cells, and depends on the molecular subtype of the invasive breast carcinoma
Hee Jung Kwon et al.
HISTOPATHOLOGY (2017)
Tracing the origins of relapse in acute myeloid leukaemia to stem cells
Liran I. Shlush et al.
NATURE (2017)
Identification of Interleukin-1 by Functional Screening as a Key Mediator of Cellular Expansion and Disease Progression in Acute Myeloid Leukemia
Alyssa Carey et al.
CELL REPORTS (2017)
CD45RA, a specific marker for leukaemia stem cell sub-populations in acute myeloid leukaemia
Bas Kersten et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
CD9, a key actor in the dissemination of lymphoblastic leukemia, modulating CXCR4-mediated migration via RAC1 signaling
Marie-Pierre Arnaud et al.
BLOOD (2015)
Acute Myeloid Leukemia
Hartmut Doehner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Absence of CD9 expression in acute myeloid leukemia: possible correlation with t(8;21)
S. K. Gupta et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2015)
Tetraspanin proteins promote multiple cancer stages
Martin E. Hemler
NATURE REVIEWS CANCER (2014)
NPM1-mutated acute myeloid leukemia of monocytic or myeloid origin exhibit distinct immunophenotypes
Yan-Rong Liu et al.
LEUKEMIA RESEARCH (2013)
Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
Li Ding et al.
NATURE (2012)
Regulation of cancer stem cell properties by CD9 in human B-acute lymphoblastic leukemia
Hiroto Yamazaki et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Coexistence of LMPP-like and GMP-like Leukemia Stem Cells in Acute Myeloid Leukemia
Nicolas Goardon et al.
CANCER CELL (2011)
CD34+ cells from AML with mutated NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia in immunocompromised mice
Maria Paola Martelli et al.
BLOOD (2010)
TIM-3 Is a Promising Target to Selectively Kill Acute Myeloid Leukemia Stem Cells
Yoshikane Kikushige et al.
CELL STEM CELL (2010)
CD9 correlates with cancer stem cell potentials in human B-acute lymphoblastic leukemia cells
Hiroko Nishida et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
The novel AML stem cell-associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells
Anna van Rhenen et al.
BLOOD (2007)
A specific microdomain (glycosynapse 3) controls phenotypic conversion and reversion of bladder cancer cells through GM3-mediated interaction of α3β1 integrin with CD9
K Mitsuzuka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Down-regulation of CD9 in human ovarian carcinoma cell might contribute to peritoneal dissemination:: Morphologic alteration and reduced expression of β1 integrin subsets
M Furuya et al.
CANCER RESEARCH (2005)
Expression of tetraspanins in peripheral blood leukocytes: a comparison between normal and infectious conditions
T Tohami et al.
TISSUE ANTIGENS (2004)
The tetraspanin CD9 is preferentially expressed on the human CD4+CD45RA+ naive T cell population and is involved in T cell activation
H Kobayashi et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
Multiple levels of interactions within the tetraspanin web
S Charrin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells
CT Jordan et al.
LEUKEMIA (2000)
分享论文
